Related Experiment Video
Updated: Jul 2, 2026

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer
Published on: October 31, 2025
Nutritional Support for Treatment Continuity and Survival in Advanced Gastric Cancer: A Propensity Score-matched
Keiji Sugiyama1,2, Takumi Ito3, Masahiro Yaguchi3
1Department of Medical Oncology, NHO Nagoya Medical Center, Aichi, Japan; keiji.sugi@gmail.com.
Background/Aim:
This study aimed to clarify the effect of nutritional support in patients with advanced gastric cancer (AGC) receiving first-line chemotherapy.
Patients And Methods:
We retrospectively reviewed the medical records of consecutive patients with unresectable or recurrent AGC treated with first-line chemotherapy at Nagoya Medical Center between 2007 and 2024. Patients who received nutritional support were compared with those without nutritional support. Nutritional support included individualized dietary counselling, assessment of energy and protein requirements, and multidisciplinary evaluation. Propensity score matching (PSM, 1:1) was applied to adjust for baseline nutritional and inflammatory status. The primary endpoint was time to treatment failure (TTF). Subgroup analyses were conducted by baseline albumin level.
Results:
Among the 324 eligible patients included in the analysis, 76 received nutritional support. Before PSM, patients who were provided nutritional support more frequently presented with poor nutritional profiles. After PSM (n=46 per group), the median TTF was 5.0 months in patients without nutritional support and 4.6 months in those with it. In patients with hypoalbuminemia (albumin <3.5 g/dl), nutritional support significantly prolonged TTF. Finally, multivariate analysis in the pre-PSM cohort identified nutritional support as an independent predictor of TTF.
Conclusion:
Although nutritional support was not associated with significant TTF improvement in the overall AGC population after propensity score matching, it emerged as an independent predictor of treatment continuity in multivariate analysis of the pre-PSM cohort. This benefit was particularly evident in patients with hypoalbuminemia, indicating that targeted nutritional intervention is essential for this vulnerable subgroup to prevent premature treatment failure.
Related Concept Videos
Cancer Survival Analysis
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Treatment Resistant Cancers
Treatment Resistent Cancers
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...